中文 | English
Return
Total: 960 , 1/96
Show Home Prev Next End page: GO
Author:(Hai-Hong LIU)

2.Lead compound optimization strategy (2)--structure optimization strategy for reducing toxicity risks in drug design.

Hai-Long LIU ; Jiang WANG ; Dai-Zong LIN ; Hong LIU

Acta Pharmaceutica Sinica 2014;49(1):1-15

7.Clinical and Radiographic Features of Short Stature Combined with Skeletal Deformity in Children

hai-yan, LI ; hong-wei, MA ; wei-liang, LIU

Journal of Applied Clinical Pediatrics 2006;0(20):-

8.Protective effects and mechanism of dihydromyricetin on non-alcoholic fatty liver disease in ApoE-/-mice

hong Hai LIU

Chinese Traditional Patent Medicine 2017;39(12):2448-2453

9.Investigation of Microcystin-LR Pollution in Large Reservoirs in Taiyuan

Zhi-Hong ZHANG ; Guo-Guo QIAO ; Hai-Fang LIU ;

Journal of Environment and Health 2007;0(08):-

10.Effect of Rehabilitation on Unilateral Spatial Neglect after Stroke

Ying HAI ; Wei LIU ; Xuena LI ; Hong ZHAO

Chinese Journal of Rehabilitation Theory and Practice 2008;14(5):454-456

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 960 , 1/96 Show Home Prev Next End page: GO